Abstract: A movable core is driven by a magnetic attraction force with a fixed core to move a valve body to inject fuel. A yoke accommodates the fixed core. A coil is in a coil chamber between the fixed core and the yoke. The coil chamber is filled with a filling resin member being electrically insulative. The fixed core has a core facing surface facing the movable core and includes a protruding portion that protrudes radially outer side and is in contact with the yoke to conduct the magnetic flux. A resin molding flow channel is formed in the protruding portion to cause molten resin serving as the filling resin member to flow into the coil chamber. A length of the protruding portion along a cylinder center line is set to be shorter toward a radially outer side.

Abstract: The present invention relates to a method for assessing mitochondrial function in a tissue or organ other than the kidney in a test subject, including: a step of calculating a ratio (BUN/CRE) of blood urea nitrogen (BUN) concentration to blood creatinine (CRE) concentration in a test subject; and a step of estimating mitochondrial activity in a tissue or organ other than the kidney in the test subject using the calculated ratio (BUN/CRE).

Abstract: The present invention relates to an agent for detecting an interaction between tissues and organs, the agent containing a compound represented by General Formula (1-0) as an active component. [In General Formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n—, or —CH2O(CH2)nOC2H4—, n represents an integer of 1 to 5, and Q1 represents F or —OCH3].

Abstract: The present invention relates to a method for diagnosing a pancreatic function, including: a step of administering a diagnostic agent for a pancreatic function which contains a compound represented by General Formula (1-0) as an active component to a subject; a step of detecting the compound (1-0) accumulated in the pancreas; and a step of quantitatively analyzing an amount of compound (1-0) accumulated in the pancreas. [In General Formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n—, or —CH2O(CH2)nOC2H4—, n represents an integer of 1 to 5, and Q1 represents F or —OCH3].

Abstract: A plurality of injection holes include at least one flat injection hole while an outlet opening of the at least one flat injection hole has a long axis and a short axis, and the at least one flat injection hole includes at least one specific flat injection hole. The specific flat injection hole has an injection hole axis that connects between a center of an inlet opening and a center of the outlet opening, and the long axis of the outlet opening is perpendicular to a plane which includes the injection hole axis and is parallel with the valve axis. An inner wall of the outlet opening has two planar portions which are opposed to each other while the long axis is interposed between the planar portions.

Abstract: The present invention relates to a compound represented by the following General Formula (1) or a salt thereof. In General Formula (1), R1, R2, R3 and R4 each independently represent a hydrogen atom, a linear or branched alkyl group which may have a substituent or the like. R1 and R2 may be bonded to each other to form a ring. R3 and R4 may be bonded to each other to form a ring. R1 and/or R2 may be bonded to a 6-membered ring to which —NR1R2 is bonded to form a ring. R3 and/or R4 may be bonded to a 6-membered ring to which —NR3R4 is bonded to form a ring. R5 represents —11CH3, a linear or branched alkyl group which may have a substituent or the like. R6 represents —F, —18F or the like. X, Y and Z each independently represent a carbon atom, an oxygen atom or the like. n is 0 or 1.

Abstract: A movable core is driven by a magnetic attraction force with a fixed core to move a valve body to inject fuel. A yoke accommodates the fixed core. A coil is in a coil chamber between the fixed core and the yoke. The coil chamber is filled with a filling resin member being electrically insulative. The fixed core has a core facing surface facing the movable core and includes a protruding portion that protrudes radially outer side and is in contact with the yoke to conduct the magnetic flux. A resin molding flow channel is formed in the protruding portion to cause molten resin serving as the filling resin member to flow into the coil chamber. A length of the protruding portion along a cylinder center line is set to be shorter toward a radially outer side.

Abstract: An inflator (3) includes an inflator main body (10) which is has a tubular shape and has a plurality of gas injection holes (11) on a circumferential surface, and a steel-made collar member (20) which has a gas jet reception part (28) that is disposed so as to face a gas injection holes formation area (R) of the inflator main body (10) across a space.

Abstract: The present invention provides a diagnostic agent for a therapeutic effect on cancer, containing a compound represented by formula (1-0). (In formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n—, or —CH2O(CH2)nOC2H4—, n represents an integer of 1 to 5, and Q1 represents F or —OCH3.

Abstract: The present invention provides a compound represented by formula (I), wherein in formula (I), R1 represents CH3, F, (CH2)n—F, NH—(CH2)n—F, O—(CH2)n—F or S—(CH2)n—F, and n represents an integer of 1 to 3.

Abstract: Provided is a compound represented by formula (1-0): wherein in formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n— or —CH2O(CH2)nOC2H4—; n represents an integer from 1 to 5; and Q1 represents F or —OCH3.

Abstract: An inflator (3) includes an inflator main body (10) which is has a tubular shape and has a plurality of gas injection holes (11) on a circumferential surface, and a steel-made collar member (20) which has a gas jet reception part (28) that is disposed so as to face a gas injection holes formation area (R) of the inflator main body (10) across a space.

Abstract: The present invention provides a diagnostic agent for a therapeutic effect on cancer, containing a compound represented by formula (1-0). (In formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n—, or —CH2O(CH2)nOC2H4—, n represents an integer of 1 to 5, and Q1 represents F or —OCH3.

Abstract: It is intended to provide a radioactive tyrosine derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 represents a group selected from the group consisting of —11CH3, —11CH2CH3, —CH218F, and —CH2CH2CH218F.

Abstract: The present invention provides a compound represented by formula (I), wherein in formula (I), R1 represents CH3, F, (CH2)n—F, NH—(CH2)n—F, O—(CH2)n—F or S—(CH2)n—F, and n represents an integer of 1 to 3.

Abstract: Provided is a compound represented by formula (1-0): wherein in formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n— or —CH2O(CH2)nOC2H4—; n represents an integer from 1 to 5; and Q1 represents F or —OCH3.

Abstract: A method of rapid methylation of an aromatic compound or an alkenyl compound, which is capable of obtaining an aromatic compound or an alkenyl compound labeled with a methyl group or a fluoromethyl group under a mild condition rapidly in high yield using an organic boron compound whose toxicity is not so high as a substrate. A kit for preparing a PET tracer and a method of producing a PET tracer can be practiced using the rapid methylation method. In an aprotic polar solvent, methyl iodide or X—CH2F (wherein X is a functional group which can be easily released as an anion), and an organic boron compound in which an aromatic ring or an alkenyl group is attached to boron are subjected to cross-coupling in the presence of a palladium(0) complex, a phosphine ligand, and a base.

Abstract: The present invention provides a carbon monoxide removal agent that can be easily administered to a patient by injection or orally. The carbon monoxide removal agent of the present invention contains, as an active ingredient, an inclusion complex in which a cyclodextrin dimer represented by chemical formula (1) below includes a water-soluble metalloporphyrin. (In the formula, m represents either of number 1 or 2 and n represents any of number 1, 2, or 3.

Abstract: Disclosed is a kit for use in the production of a molecular probe for PET drug screening for the purpose of producing a compound containing a short-lived radionuclide for PET applications. Specifically disclosed is a kit comprising a compound represented by the formula (I), (II) or (III) or a salt thereof. In the formulae, X1, X2, X3, X4, X5 and X6 are as defined in the description.

Abstract: It is intended to provide a method of rapid methylation of an aromatic compound or an alkenyl compound, which is capable of obtaining an aromatic compound or an alkenyl compound labeled with a methyl group or a fluoromethyl group under a mild condition rapidly in high yield using an organic boron compound whose toxicity is not so high as a substrate; a kit for preparing a PET tracer to be used in the same, and a method of producing a PET tracer using the same. In an aprotic polar solvent, methyl iodide or X—CH2F (wherein X is a functional group which can be easily released as an anion), an organic boron compound in which an aromatic ring or an alkenyl group is attached to boron are subjected to cross-coupling in the presence of a palladium(0) complex, a phosphine ligand, and a base.